A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models

Vaccine
Flavia De BernardisAntonio Cassone

Abstract

A novel vaccine (PEV7) consisting of a truncated, recombinant aspartyl proteinase-2 of Candida albicans incorporated into influenza virosomes was studied. This vaccine candidate generated a potent serum antibody response in mouse and rat following intramuscular immunization. Anti-Sap2 IgG and IgA were also detected in the vaginal fluid of rats following intravaginal or intramuscular plus intravaginal administration. In a rat model of candidal vaginitis, PEV7 induced significant, long-lasting, likely antibody-mediated, protection following intravaginal route of immunization. PEV7 was also found to be safe in a repeated-dose toxicological study in rats. Overall, these data provide a sound basis to envisage the clinical development of this new candidate vaccine against candidal vaginitis.

References

Nov 1, 1987·The Journal of Infectious Diseases·A CassoneL Agatensi
Sep 15, 2001·Medical Mycology·F De BernardisA Cassone
Aug 17, 2002·Current Drug Targets·M BeinH C Korting
Sep 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Julian R NaglikBernhard Hube
Sep 2, 2004·Cellular Microbiology·Julian NaglikBernhard Hube
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oksana BabulaSteven S Witkin
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marcio Nucci, Kieren A Marr
Sep 9, 2005·The Journal of Experimental Medicine·Antonella TorosantucciAntonio Cassone
Jun 17, 2006·The Journal of Infectious Diseases·Brad J SpellbergJohn E Edwards
Jul 6, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jennifer M Dan, Stuart M Levitz
Dec 13, 2006·Nature Reviews. Microbiology·Jim E CutlerBruce S Klein
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Jun 15, 2007·Lancet·Jack D Sobel
Jun 15, 2007·Infection and Immunity·Antonio CassoneGiorgio Santoni
Jan 29, 2008·The Lancet Infectious Diseases·Antonio Cassone
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hong XinJim E Cutler
Oct 11, 2008·Expert Review of Vaccines·Patrick A Bovier
May 20, 2009·Vaccine·Christian HerzogReinhard Glück
Nov 3, 2009·Molecular Immunology·Katharina GroppChristine Skerka
Aug 14, 2010·Trends in Immunology·Mihai G Netea, László Maródi
Feb 11, 2011·Current Infectious Disease Reports·Paul L Fidel, Jim E Cutler
Apr 22, 2011·Expert Review of Vaccines·Christian MoserRinaldo Zurbriggen

❮ Previous
Next ❯

Citations

Apr 5, 2014·PLoS Pathogens·Brian M PetersPaul L Fidel
Apr 4, 2013·Molecular Pharmaceutics·Gaëlle VacherGerrit Borchard
Oct 17, 2015·Pathogens·Flavia De BernardisSandro Norelli
Jun 25, 2014·Expert Review of Vaccines·Maria Dolores MoraguesGuillermo Quindos
Jul 28, 2013·Expert Review of Vaccines·Christian MoserMario Amacker
Jun 25, 2014·Drug Delivery·Himmat Singh JohalAmit Kumar Goyal
Feb 19, 2016·Advanced Healthcare Materials·Yanyan HuaiChuanbin Mao
Feb 11, 2016·Computational and Structural Biotechnology Journal·Jacinto López-SagasetaMatthew J Bottomley
Dec 24, 2015·Applied Microbiology and Biotechnology·Janine Silva Ribeiro GodoyTerezinha Inez Estivalet Svidzinski
Jul 24, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·A Cassone
Apr 15, 2016·Virulence·Yulin QinYongbing Cao
Jan 7, 2015·Virulence·Xiao-juan WangYuan-ying Jiang
Feb 24, 2015·Cellular and Molecular Life Sciences : CMLS·Elizabeth J PolviLeah E Cowen
May 9, 2012·Current Opinion in Microbiology·Antonio Cassone, Arturo Casadevall
Nov 19, 2014·Seminars in Immunopathology·Sri Ramulu ElluruJagadeesh Bayry
Nov 5, 2014·Medical Mycology·Deivys Leandro F PortuondoIracilda Z Carlos
Jul 16, 2013·PLoS Pathogens·Antonella De LucaLuigina Romani
Dec 23, 2016·PLoS Pathogens·Antonio CassoneBernhard Hube
Nov 26, 2015·Memórias do Instituto Oswaldo Cruz·Natasha P Medici, Maurizio Del Poeta
Nov 5, 2014·Therapeutic Advances in Vaccines·Reto A Schwendener
Mar 15, 2018·Medical Mycology·Flavia De BernardisStavroula Antonopoulou
Jul 9, 2016·MSphere·Luna S JoffeMaurizio Del Poeta
Feb 18, 2016·Infection and Immunity·Antonio Cassone, Jack D Sobel
May 17, 2018·Journal of Innate Immunity·Fabián Salazar, Gordon D Brown
Nov 16, 2013·Nature Reviews. Microbiology·Antonio Cassone
May 15, 2018·Frontiers in Immunology·Gloria Hoi Wan TsoNorman Pavelka
Feb 29, 2020·Journal of Fungi·Hubertine M E WillemsBrian M Peters
Jun 20, 2020·Cellular Microbiology·Gabriele VargasLeonardo Nimrichter
Jan 25, 2020·Scientific Reports·Shikha TarangMichael D Weston
Oct 18, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jaroslava DekkerováHelena Bujdáková
Nov 12, 2020·Journal of Fungi·Valentina SustrAlex Farr
Nov 7, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sanam NamiHamid Morovati
Mar 5, 2021·NPJ Vaccines·Lorena V N OliveiraStuart M Levitz
Apr 14, 2021·Microbial Pathogenesis·Nahid AkhtarM Amin-Ul Mannan
Jul 20, 2021·Advanced Drug Delivery Reviews·Chao PanHeng-Liang Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.